HeartForce is proud to have been selected as a top 5 company for “Patient Monitoring” by Bayer and has been invited to participate in the company’s 2020 Cardiovascular Growth Challenge. HeartForce was selected as one of the finalists from who participated in the Bayer AG Deutschland G4A Partnership program. The G4A Partnership Program offers leading… Continue reading HeartForce Selected as Top 5 Company and Reaches Final Stage of G4A Partnerships Program with Bayer